A Call to Investigate IL-17 as Drug Target for Lung Cancer, COVID-19
Interleukin 17 may be a therapeutic target worth investigating for patients with lung cancer and SARS-CoV-2 infection, existing literature suggests.
Cancer
Hepatocellular Carcinoma Prediction Beyond Year 5 of Therapy in Chronic Hepatitis B
A study identifies risk factors for hepatocellular carcinoma (HCC) after the first 5 years of receiving antiviral therapy in white patients with chronic hepatitis B.
Harnessing Key Elements of the Ebola Virus in Animal Models of Glioblastoma
A glycoprotein in Ebola called the mucin-like domain may be of interest in the development of an oncolytic for brain cancer.
Mortality Risk Among Patients With Oropharynx Cancer Varies Based on HPV Status
For patients with oropharynx cancer, the rates of head and neck cancer mortality and competing mortality vary depending on HPV status.
Sepsis-Associated Mortality Rates Have Improved in Patients With Cancer
From 2003 to 2014, sepsis-associated mortality rates significantly declined in patients with cancer, yet these rates have remained relatively unchanged in patients without cancer.
Routine HPV Testing May Be Warranted for Sinonasal Cancers
Only one in four patients with sinonasal squamous cell carcinoma is tested for human papillomavirus.
Epidemiologic Associations Between HTLV-1 and Adverse Health Outcomes
In a study published in The Lancet Infectious Diseases, investigators demonstrated a significant gap in research on human T-cell lymphotropic virus type 1 (HTLV-1) and the effect of comorbidities on mortality in patients with this infection.
H pylori Infection Must Be Eradicated to Decrease Gastric Cancer Risk
Risk for gastric cancer tied to H. pylori infection higher in blacks, Asians, Hispanics/Latinos
Common TB Vaccine Associated With Lower Lung Cancer Rates
In 60-year follow-up, significantly lower lung cancer rates seen for those with childhood BCG vaccination
Predictors of Immune Response to HBV Vaccine Identified in Lymphoma
For patients with lymphoma, the dose and frequency of HBV, sex, Ann Arbor stage, and ibrutinib as part of the chemotherapy regimen are independent factors that affect the impact of the vaccine.
-
Loading...
-
Loading...
Next post in Hepatitis
